¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦51ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2021-11-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦51ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2021-11-27
±³À°ÀÏÀÚ : 2021-11-27
±³À°Àå¼Ò : ¿Â¶óÀÎ(½Ç½Ã°£ È­»ó °­ÀÇ), ¿ÀÇÁ¶óÀÎ(±×·£µå ¿öÄ¿Èú, ¼­¿ï)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ ¿ÀÇÁ¶óÀÎ º´Çà) Á¦51ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ
´ã´çÀÚ : ±è´ÙÇý
¿¬¶ôó : 02-3147-0930  
À̸ÞÀÏ : ksecho4@ksecho.org      
±³À°Á¾·ù : ³»°úÀÇÇб³À°
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 18ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í [¿ÀÇÁ¶óÀÎ-(°³¿ø)Àü¹®ÀÇ,ÀüÀÓÀÇ,±ºÀÇ°ü µî 8¸¸¿ø / Àü°øÀǹױ⟠4¸¸¿ø][¿Â¶óÀÎ-(°³¿ø)Àü¹®ÀÇ,ÀüÀÓÀÇ,±ºÀÇ°ü µî 2¸¸¿ø / Àü°øÀǹױ⟠1¸¸¿ø]      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 09:00~09:15 Updates in the diagnosis and echo approach  ¹®Á¤±Ù(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 09:15~09:30 Risk of sudden death  ±èÇü°ü(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 09:30~09:45 Novel treatment approach  ¾çµ¿Çå(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 09:45~10:00 Surgery for HCM  ±è°æȯ(¼­¿ïÀÇ´ë) 
Åä·Ð 11-27 ºñ½ºÅ¸2 10:00~10:20 Panel Discussion  () 
È޽Ġ11-27 ºñ½ºÅ¸2 10:20~10:50 Coffee Break  () 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 10:50~11:03 Association of anti-citrullinated peptide antibodies with the progression of aortic stenosis  ±è¾Æ¶÷(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 11:03~11:16 Late leaflet thrombosis after transcatheter aortic valve replacement  ¹Ú¹ÎÁ¤(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 11:16~11:29 Adjustment of Pressure Recovery versus Aortic Valve Calcium Score to Improve Concordance in Severity Assessment in Patients with Predominantly Severe Aortic Stenosis Impact of Different Race  ¿ÀÁø°æ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 11:29~11:42 Echocardiographic diastolic parameters as a predictor of Cardiovascular events after living donor kidney transplantation.  À±ÇöÁö(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 11:42~11:55 Non-invasive estimation of left atrial pressure in patients with atrial fibrillation  ¼­Áö¿ø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-27  11:55~12:08 Long-term prognostic value of reduced and borderline left ventricular ejection fraction in hypertrophic cardiomyopathy  ÃÖÀ¯Á¤(¼­¿ïÀÇ´ë) 
±âŸ 11-27 ºñ½ºÅ¸2 12:10~12:15 Opening  () 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 12:15~12:35 Protecting Patients with DM and NVAF  ¹è¸íȯ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 12:35~12:55 Protecting Patients with Cancer Associated Thrombosis  ±èÀº°æ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 12:55~13:15 Protecting Patients with Poly-vascular disease  ÀÌÁ¾¿µ(¼º±Õ°üÀÇ´ë) 
±âŸ 11-27 ºñ½ºÅ¸2 13:15~13:20 Closing  () 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 13:20~13:40 HF  ±èÀÎö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 13:40~14:00 Valvular Heart Disease  Çã¶õ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 14:00~14:20 Coronary Heart Disease  ÀÌÁÖ¸í(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 14:20~14:40 Atrial Fibrillation  ÃÖÁ¾ÀÏ(°í·ÁÀÇ´ë) 
È޽Ġ11-27 ºñ½ºÅ¸2 14:40~15:10 Coffee Break  () 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 15:10~15:25 Pulmonary hypertension and evaluation of right heart cirulcation system  ¼ÛÁ¾¹Î(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 15:25~15:40 Pulmonary arterial hypertension: Update  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 15:40~15:55 Combined pre and post-capillary pulmonary hypertension  Á¶À翵(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-27 ºñ½ºÅ¸2 15:55~16:10 Pulmonary thromboembolism : acute and chronic  À强¾Æ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 11-27 ºñ½ºÅ¸2 16:10~16:30 Panel Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦51ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ : 2021-11-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Çѱ¹°Ç°­°ËÁøÇÐȸ Á¦2ȸ Ãß°èÇмú´ëȸ : 2021-11-28
´ÙÀ½±Û 2021 ´ëÇѵΰ³ÀúÇÐȸ Á¤±âÇмú´ëȸ : 2021-11-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20620 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼­¿ï¾Æ»êº´¿ø ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-30 0 84 2024-04-30
20619 °æ³² »ï¼ºÃ¢¿øº´¿ø (¿Â¶óÀÎ)»ï¼ºÃ¢¿ø Ambulatory Pediatrics 2024 : 2024-06-29 0 67 2024-04-30
20618 °æºÏ Á¦8Â÷ ´ëÇѸðüžÆÀÇÇÐȸ °³¿øÀǸ¦ À§ÇÑ ¿¬¼ö°­ÁÂ(¿µ³²) : 2024-06-29 0 32 2024-04-30
20617 ¼­¿ï °Ç±¹´ëÇб³º´¿ø 2024 KUMC Precision Medicine Lung Cancer Conference : 2024-06-28 0 23 2024-04-30
20616 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ ÀûÇ÷±¸Áúȯ¿¬±¸ ½ÉÆ÷Áö¾ö : 2024-06-28 0 41 2024-04-30
20615 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-°³¿ø°¡¿¡¼­ ÀÇ·ÚÇÑ µÎ°æºÎ¾Ï ȯÀÚÀÇ Ä¡·á ¹× °æ°ú : 2024-06-27 0 28 2024-04-30
20614 ¼­¿ï 2024³â ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 24 2024-04-30
20613 ´ë±¸ ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ Sports Medicine Symposium 2024 in Daegu : 2024-06-23 0 45 2024-04-29
20612 ¼­¿ï 2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦12Â÷ Clinical Densitometry Course : 2024-06-23 0 43 2024-04-29
20611 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(2ÀÏÂ÷) : 2024-06-22 0 47 2024-04-29
20610 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 6¿ù 21ÀÏ ±Ý¿äÁý´ãȸ(ÀÌ°ü ÁúȯÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-21 0 38 2024-04-29
20609 °æ±â ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¾È¸é¸¶ºñ) : 2024-06-21 0 29 2024-04-29
20608 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(1ÀÏÂ÷) : 2024-06-21 0 42 2024-04-29
20607 ¼­¿ï 2024 ´ëÇÑȯ°æõ½ÄÆóÁúȯÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-21 0 36 2024-04-29
20606 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¿Ü·¡¿¡¼­ °£´ÜÇÏ°Ô ÇÒ ¼ö ÀÖ´Â À½¼ºÄ¡·á : 2024-06-20 0 26 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷